PRGO Insider Trading
PERRIGO Co plc | Pharmaceutical Preparations
Comprehensive Trading Performance Summary
The investment history of corporate insiders at PERRIGO Co plc provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-14 18:45 | 2025-11-12 | Parker Geoffrey M. | Director | BUY | $14.18 | 7,500 | $106,350 | 17,375 | +75.9% |
| 2025-09-10 23:19 | 2025-09-08 | Lennox Abigail | Officer - EVP and CSO | BUY | $22.41 | 1,255 | $28,125 | 1,255 | +100.0% |
| 2025-09-09 22:47 | 2025-09-05 | Atkinson Charles | Officer - EVP, General Counsel & Sec. | BUY | $23.20 | 1,000 | $23,200 | 1,000 | +100.0% |
| 2025-08-22 20:27 | 2025-08-22 | Willis Robert | Officer - EVP & CHRO | BUY | $24.10 | 1,488 | $35,858 | 41,939 | +3.7% |
| 2025-08-20 15:11 | 2025-08-18 | Parker Geoffrey M. | Director | BUY | $22.97 | 4,375 | $100,497 | 9,875 | +79.5% |
| 2025-08-19 17:56 | 2025-08-18 | Parker Geoffrey M. | Director | BUY | $22.97 | 4,375 | $100,497 | 33,287 | +15.1% |
| 2025-08-19 17:41 | 2025-08-18 | Bezerra Eduardo Guarita | Officer - EVP & Chief Financial Officer | BUY | $22.74 | 3,000 | $68,207 | 48,949 | +6.5% |
| 2025-08-08 18:45 | 2025-08-08 | Lockwood-Taylor Patrick | Director, Officer - CEO | BUY | $22.37 | 4,460 | $99,766 | 85,812 | +5.5% |
| 2025-05-14 21:06 | 2025-05-12 | Parker Geoffrey M. | Director | BUY | $27.10 | 3,500 | $94,850 | 23,762 | +17.3% |
| 2025-03-11 03:07 | 2025-03-10 | Janish Ronald Craig | Officer - EVP, Gbl Ops & SC & CTO | OPT+S | $27.44 | 7,800 | $214,032 | 33,666 | 0.0% |
| 2024-12-10 18:45 | 2024-12-09 | KINDLER JEFFREY B | Director | SELL | $28.27 | 17,598 | $497,495 | 5,409 | -76.5% |
| 2024-09-13 22:28 | 2024-09-13 | Doyle Katherine C. | Director | SELL | $27.30 | 8,954 | $244,444 | 6,009 | -59.8% |
| 2024-08-29 00:17 | 2024-08-26 | Janish Ronald Craig | Officer - EVP, Gbl Ops & SC & CTO | SELL | $29.40 | 13,000 | $382,246 | 20,553 | -38.7% |
| 2024-08-21 16:20 | 2024-08-20 | Andersen Svend | Officer - EVP & President CHCI | SELL | $27.69 | 34,983 | $968,560 | 7,000 | -83.3% |
| 2024-06-01 00:04 | 2024-05-28 | Andersen Svend | Officer - EVP & President CHCI | BUY | $27.90 | 1,000 | $27,900 | 101,853 | +1.0% |
| 2024-03-08 05:58 | 2024-03-05 | Ives Alison | Officer - EVP & Chief Scientific Officer | BUY | $27.26 | 2,490 | $67,877 | 16,122 | +18.3% |
| 2024-03-08 05:54 | 2024-02-29 | Ives Alison | Officer - EVP & Chief Scientific Officer | BUY | $26.44 | 1,545 | $40,850 | 12,446 | +14.2% |
| 2024-03-08 05:47 | 2023-11-16 | Ives Alison | Officer - EVP & Chief Scientific Officer | BUY | $29.34 | 2,040 | $59,854 | 10,901 | +23.0% |
| 2024-03-01 22:31 | 2024-02-29 | Willis Robert | Officer - EVP & CHRO | BUY | $25.90 | 6,371 | $164,977 | 25,476 | +33.3% |
| 2024-02-29 21:39 | 2024-02-29 | Lockwood-Taylor Patrick | Director, Officer - CEO | BUY | $26.54 | 9,500 | $252,168 | 20,500 | +86.4% |
| 2023-11-28 03:12 | 2023-11-24 | Willis Robert | Officer - EVP & CHRO | BUY | $31.01 | 5,550 | $172,106 | 19,105 | +40.9% |
| 2023-11-17 14:03 | 2023-11-16 | Ives Alison | Officer - EVP & Chief Scientific Officer | BUY | $29.34 | 2,040 | $59,854 | 10,380 | +24.5% |
| 2023-11-15 20:14 | 2023-11-14 | Bezerra Eduardo Guarita | Officer - EVP & Chief Financial Officer | BUY | $29.18 | 5,000 | $145,882 | 8,428 | +145.9% |
| 2023-11-15 03:12 | 2023-11-14 | Lockwood-Taylor Patrick | Director, Officer - CEO | BUY | $28.99 | 11,000 | $318,868 | 11,000 | +100.0% |
| 2023-06-14 17:54 | 2023-06-13 | Parker Geoffrey M. | Director | BUY | $33.06 | 10,000 | $330,637 | 25,879 | +63.0% |
| 2023-05-25 15:16 | 2023-05-23 | Andersen Svend | Officer - EVP & President CHCI | BUY | $33.41 | 2,900 | $96,902 | 68,741 | +4.4% |
| 2023-05-15 18:03 | 2023-05-11 | KESSLER MURRAY S | Director, Officer - CEO | SELL | $35.75 | 197,646 | $7,066,358 | 2,668 | -98.7% |
| 2023-03-14 16:38 | 2023-03-10 | Dillard James E III | Officer - EVP & President CSCA | SELL | $35.70 | 9,000 | $321,309 | 25,130 | -26.4% |
| 2023-03-14 16:14 | 2023-03-13 | Farrington Thomas | Officer - EVP and CIO | SELL | $35.57 | 3,723 | $132,435 | 2,823 | -56.9% |
| 2023-03-10 02:09 | 2023-03-08 | Janish Ronald Craig | Officer - EVP, Gbl Ops & SC & CTO | SELL | $36.92 | 4,500 | $166,133 | 20,191 | -18.2% |
| 2023-03-07 15:48 | 2023-03-06 | Parker Geoffrey M. | Director | BUY | $38.05 | 5,000 | $190,270 | 15,879 | +46.0% |
| 2022-12-20 15:51 | 2022-12-16 | Quinn Grainne | Officer - EVP, Chief Medical Officer | SELL | $31.65 | 2,368 | $74,947 | 9,118 | -20.6% |
| 2022-03-16 20:26 | 2022-03-14 | Farrington Thomas | Officer - EVP and CIO | SELL | $37.14 | 26,744 | $993,181 | 0 | -100.0% |
| 2022-03-09 00:58 | 2022-03-07 | Janish Ronald Craig | Officer - EVP, Gbl Ops & SC & CTO | OPT+S | $36.73 | 3,954 | $145,232 | 15,686 | 0.0% |
| 2021-12-20 20:05 | 2021-12-17 | KINGMA TODD W | Officer - Executive VP, General Counsel | BUY | $37.55 | 3,000 | $112,648 | 51,856 | +6.1% |
| 2021-12-17 20:34 | 2021-12-16 | Parker Geoffrey M. | Director | BUY | $36.85 | 5,000 | $184,270 | 10,879 | +85.0% |
| 2021-12-16 23:39 | 2021-12-16 | Alford Bradley A | Director | BUY | $36.88 | 13,000 | $479,409 | 23,978 | +118.4% |
| 2021-12-07 19:12 | 2021-12-06 | Andersen Svend | Officer - EVP & President CHCI | BUY | $37.10 | 3,655 | $135,599 | 13,683 | +36.4% |
| 2021-12-06 16:31 | 2021-12-03 | SILCOCK RAYMOND | Officer - EVP, Chief Financial Officer | BUY | $36.03 | 27,500 | $990,930 | 37,696 | +269.7% |
| 2021-12-03 19:10 | 2021-12-02 | CLASSON ROLF A | Director | BUY | $35.67 | 2,800 | $99,874 | 17,442 | +19.1% |
| 2021-03-18 21:45 | 2021-03-17 | Parker Geoffrey M. | Director | BUY | $41.29 | 2,500 | $103,218 | 2,650 | +1,666.7% |
| 2021-03-11 23:57 | 2021-03-10 | Janish Ronald Craig | Officer - EVP, Gbl Ops & SC & CTO | SELL | $41.23 | 2,662 | $109,766 | 11,731 | -18.5% |
| 2021-01-07 20:31 | 2021-01-06 | Sorota Richard S | Officer - EVP & President CSCA | BUY | $43.48 | 7,513 | $326,665 | 7,513 | +100.0% |
| 2020-11-10 22:18 | 2020-11-09 | CLASSON ROLF A | Director | BUY | $46.75 | 2,137 | $99,898 | 10,870 | +24.5% |
| 2020-11-10 19:48 | 2020-11-09 | Samuels Theodore R. II | Director | BUY | $46.91 | 4,500 | $211,112 | 18,118 | +33.0% |
| 2020-08-11 17:58 | 2020-08-11 | Andersen Svend | Officer - EVP & President CHCI | BUY | $53.01 | 2,828 | $149,910 | 10,028 | +39.3% |
| 2020-05-12 00:05 | 2020-05-07 | Farrington Thomas | Officer - EVP and CIO | SELL | $52.13 | 2,000 | $104,254 | 13,405 | -13.0% |
| 2020-05-11 23:36 | 2020-05-07 | Janish Ronald Craig | Officer - EVP, Global Op. & Supply Chain | SELL | $51.90 | 2,595 | $134,671 | 8,602 | -23.2% |
| 2020-03-18 02:04 | 2020-03-13 | Samuels Theodore R. II | Director | BUY | $42.50 | 2,000 | $85,000 | 13,618 | +17.2% |
| 2019-12-23 21:31 | 2019-12-20 | KINGMA TODD W | Officer - Executive VP, General Counsel | SELL | $54.91 | 2,300 | $126,293 | 29,984 | -7.1% |
How to Interpret $PRGO Trades
Not every insider transaction in PERRIGO Co plc is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $PRGO shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for PRGO
Insider activity data for PERRIGO Co plc is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $PRGO, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.